发明名称 |
METHOD AND COMPOSITION FOR ALLEVIATING TUMOR SYMPTOMS |
摘要 |
<p>This invention relates to methods and compositions for treating carcinoid syndrome and other adverse symptoms associated with tumor-producing neuroendocrine tumors, said methods comprising administering a therapeutically effective amount of a vascular disrupting agent, or a pharmaceutically acceptable salt thereof, to a subject having a hormone producing neuroendocrine tumor. In preferred implementations, the vascular disrupting agent is combretastatin A-4 phosphate, combretastatin A-1 diphosphate, or a pharmaceutical acceptable salt thereof.</p> |
申请公布号 |
EP2863924(A1) |
申请公布日期 |
2015.04.29 |
申请号 |
EP20130806597 |
申请日期 |
2013.06.21 |
申请人 |
ANGIOGENE PHARMACEUTICALS LTD.;OXIGENE, INC. |
发明人 |
DAVIS, PETER DAVID;CHAPLIN, DAVID J. |
分类号 |
A61K31/661;A61K38/12;A61P35/00 |
主分类号 |
A61K31/661 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|